Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Moshe Oren
31.08.2022
Cancer, Viruses & Microorganisms, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Genetics
How tumors mutate their way out of a crisis – and become drug resistant in the process
16.05.2019
What happens when genes in a cancer-preventing pathway are absent?
01.05.2019
Prof. Moshe Oren has been elected as a foreign associate of the National Academy of Sciences.
19.03.2019
Two Korean concerns will invest 12 million dollars in companies based on Institute research
25.07.2018
Reeducating cells in the tumor microenvironment reverses some of the malignancy
31.07.2017
An Institute study finds a whole new role for one of the most famous proteins in cancer research
21.08.2016
Cancer, Personalized Medicine, Systems Biology, Disease, Drugs & Diagnostics, Genetics, Bioinformatics and Computational Biology, Diagnostic Techniques and Drugs
Meet the unique team of experts at the Nancy and Stephen Grand Israel National Center for Personalized Medicine
15.08.2016
Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
Mutated proteins that abet cancer growth can be turned against the cancer
01.01.2014
Drs. Harry Towbin and Benjamin Towbin talk about what drew them to the Weizmann Institute
20.08.2012
When a critical step in stem cell differentiation goes awry, it can lead to cancer
